I think I can answer that partially. We did an analysis this year of the number of cancer drugs made available to the patients of Ontario versus cancer drugs available to patients of other provinces. Ontario has the worst record of placing injunctions or restrictions or deletions or exceptions to access to these drugs. That's the same committee that's going to be the JODR. Our concern is that it will duplicate that for the country, and I think that's what you're hearing.
On April 30th, 2007. See this statement in context.